Markers of disease activity and inflammation
|
Disability (HAQ-DI)
|
0.28
|
NA
|
NA
|
Pain (VAS) (mm)
|
0.08
|
0.11
|
0.91
|
Disease activity (DASESR-28)
|
0.54
‡
|
NA
|
NA
|
ESR (mm/hour)
|
0.71
‡
|
0.24
|
0.02
|
hsCRP (mg/l)
|
0.73
‡
|
0.32
†
|
0.01
|
IL-1β (pg/ml)
|
0.19
|
0.08
|
0.62
|
IL-6 (pg/ml)
|
0.28
†
|
−0.14
|
0.05
|
IL-8 (pg/ml)
|
−0.20
|
−0.07
|
0.56
|
IL-18 (pg/ml)
|
−0.14
|
0.41
†
|
0.01
|
TNFα (pg/ml)
|
−0.09
|
−0.14
|
0.82
|
Measures of adiposity and insulin resistance
|
BMI (kg/m2)
|
0.16
|
0.38
†
|
0.28
|
Waist circumference (cm)
|
0.12
|
0.38
†
|
0.22
|
Total abdominal adiposity (cm2)
|
0.31
†
|
0.36
†
|
0.80
|
Abdominal subcutaneous adiposity (cm2)
|
0.26
|
0.34
†
|
0.70
|
Abdominal visceral adiposity (cm2)
|
0.25
|
0.21
|
0.86
|
Thigh subcutaneous adiposity (cm2)
|
0.21
|
0.55
‡
|
0.08
|
Thigh intermuscular adiposity (cm2)
|
0.06
|
0.18
|
0.60
|
Thigh muscle density (Hu)
|
−0.33
†
|
−0.14
|
0.40
|
Fasting insulin (mU/l)
|
0.18
|
0.37
†
|
0.38
|
Fasting glucose (mg/dl)
|
0.35
†
|
0.16
|
0.36
|
HOMA
|
0.17
|
0.39
†
|
0.30
|
IS index (×10–5.min−1/(pmol/l))
|
−0.26
|
−0.34
†
|
0.70
|
Acute insulin response (pmol/l)
|
0.05
|
0.48
†
|
0.04
|